Immuron (IMRN) Interest & Investment Income (2017 - 2024)

Immuron (IMRN) recorded quarterly Interest & Investment Income of $35.3 billion in Q4 2024, up 3533301692.76% quarter-over-quarter from $999.32 in Q4 2023, and up 3533301692.76% on a YoY basis from N/an in Q1 2024.

Immuron (IMRN) Interest & Investment Income (2017 - 2024) Analysis & Trends

Immuron's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $35.3 billion for Q4 2024.

  • In Q4 2024, Interest & Investment Income rose 3533301692.76% year-over-year to $35.3 billion; the TTM figure through Dec 2024 stood at $35.3 billion (up 3533301692.76% YoY), while the FY2025 annual figure was $88058.7, down 59.03% from the prior year.
  • Interest & Investment Income was $35.3 billion for Q4 2024 at Immuron, up from $999.32 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $35.3 billion in Q4 2024 to a low of -$77745.7 in Q2 2023.
  • Historically, Interest & Investment Income has averaged $3.6 billion across 5 years, with a median of $1163.2 in 2023.
  • The sharpest annual moves came in 2020 and 2023: Interest & Investment Income jumped 178613365704.8% in 2020, then plunged 398.25% in 2023.
  • A 5-year view of Interest & Investment Income shows it stood at $4.6 billion in 2020, then plunged by 100.0% to $6737.5 in 2021, then plunged by 94.73% to $355.26 in 2022, then jumped by 181.29% to $999.32 in 2023, then surged by 3533301692.76% to $35.3 billion in 2024.
  • The last three Interest & Investment Income figures came in at $35.3 billion (Q4 2024), $999.32 (Q4 2023), and $76247.4 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 597,319.59
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 305,000.00
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 103,341.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 114.80 Mn
9 Abivax 90.15 Bn 90.15 Bn - -14.79 Mn
10 Immuron 1.05 Bn 1.05 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 35.31 Bn
Dec 31, 2023 999.32
Sep 28, 2023 76,247.37
Aug 30, 2023 1,163.23
Jun 30, 2023 -77,745.69
Dec 31, 2022 355.26
Aug 31, 2022 15,149.79
Jun 30, 2022 -15,603.91
Dec 31, 2021 6,737.49
Jun 30, 2021 -7,087.59
Dec 31, 2020 4.63 Bn
Dec 31, 2019 2.59
Dec 31, 2018 39.00
Dec 31, 2017 33.51